Clinical Trial Update: Surveillance of the Genetic Signature in Circulating Tumor DNA for Guiding Adjuvant Chemotherapy in Urothelial Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating whether a circulating tumor DNA genetic signature can guide adjuvant chemotherapy decisions in patients with muscle-invasiv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle-invasive Bladder Cancer

Snippet

Sponsor: Yung NA | Conditions: Muscle Invasive Bladder Urothelial Carcinoma, Muscle-Invasive Bladder Carcinoma | Phase 2 | Status: RECRUITING